Genetic Technology Alert. 3D Bioprinting for Breast Cancer Reconstruction of Nipple Areola Complex; Enablement of Cardiovascular Tissue Using Extracellular Matrix-Based Technology

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles 3D bioprinting for breast cancer reconstruction of nipple areola complex, enablement of cardiovascular tissue using extracellular matrix-based technology, and a experimental technique for development of whole organs

Table of Contents

Genetic Technology Alert. 3D Bioprinting for Breast Cancer Reconstruction of Nipple Areola Complex; Enablement of Cardiovascular Tissue Using Extracellular Matrix-Based TechnologyIn This Issue1. 3D BIOPRINTING FOR BREAST CANCER RECONSTRUCTION OF NIPPLE AREOLA COMPLEX2. ENABLEMENT OF CARDIOVASCULAR TISSUE USING EXTRACELLULAR MATRIX-BASED TECHNOLOGY3. EXPERIMENTAL TECHNIQUE FOR DEVELOPMENT OF WHOLE ORGANS4. RECENT PATENTS IN CELLULAR SCAFFOLDS AND MATRIX5. TECHVISION 2015




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.